Auro

Aurobindo gets U.S. FDA approval for Cephalexin

Aurobindo Pharma Ltd has announced that U.S. Food Drug Administration (US FDA) has approved its Cephalexin capsules USP 250 mg & 500 mg.// Cephalexin is used to treat many different types of bacterial infections such as bronchitis, tonsillitis, ear infections, skin infections, and urinary tract infections.The company has achieved another major milestone by obtaining the first product...

US FDA approved Aurobindo Pharma to produce generic AIDS drug

The US Food and Drug Association (FDA) has approved Aurobindo Pharma Limited to produce the generic version of oral Stavudine solution// 1 mg/mL, which is used in children for control of HIV treatment. Zerit (Stavudine Oral solution) is produced commercially by Bristol-Myers Squibb which has the patent for the drug which is found to be very effective against HIV. Stavudine is a synthetic...

Aurobindo Receives Approval from USFDA for anti-AIDS drug

AIDS patients, the world over, can heave a sigh of relief following the nod of approval from the US Food & Drug Administration// (FDA) for the world’s first anti-AIDS cocktail drug for use as a single dose. The drug manufacturer, Hyderabad-based bulk drugs major Aurobindo Pharma, has made combined anti-retro virals (ARVs) — Retrovir (zidovudine), Epivir (lamivudine) and Viramune (nevira...

Aurobindo Gets Tentative USFDA Approval For Its HIV-1 Drug

Aurobindo Pharma today said it has recieved a tentative New Drug Approval from USFDA for its fixed dose combination product used for treating HIV-1 infection//. The new drug approval is for fixed dose combination drug product containing Lamivudine, Zidovudine, Nevirapine tablets used in the treatment of HIV-1 infection, the company informed the Bombay Stock Exchange. The t...

Aurobindo Pharma Purchases US Manufacturing Facility

The Hyderabad-based Aurobindo Pharma Ltd today said it has acquired a USFDA compliant manufacturing facility in Dayton, New Jersey//. The facility, spread over 20 acres of freehold land, will serve as the company's US head quarters, it informed the stock exchanges. "This purchase reinforces Aurobindo's commitment to serve US market in an effective manner," Ramprasad Reddy, C...

Aurobindo Gets USFDA Approval for Didanosine Chewable Tablets

Aurobindo Pharma Ltd today said it has received tentative approval by USFDA for its anti-HIV drug, Didanosine chewable tablets of 100mg, 150mg and 200mg strengths. // This is the first generic version approval for Didanosine chewable in the world given by USFDA, Aurobindo Pharma informed the Bombay Stock Exchange. The aforesaid product would now be available for purchase un...

Ranbaxy, Aurobinda Pharma Applauded by Annan

India's Ranbaxy Laboratories and Aurobinda Pharma were among some of the world's leading pharmaceutical and diagnostic companies applauded by UN Secretary General Kofi Annan // for their commitment to expand access to HIV/AIDS treatment and prevention. Annan complimented these companies for their efforts in the field of HIV/AIDS treatment and prevention after a meeting with their top...

Aurobindo Gets USFDA Approval for A 3-Drug Combination Pack

The Hyderabad-based Aurobindo Pharma Ltd today said it has received the tentative new drug approval for a fixed drug combination product used for anti-HIV treatment. // The fixed drug compbination product contains Lamivudine 150mg+2idovudine300mg tablets co-packaged with Abacavir 300mg Tablets, the company informed the Bombay Stock Exchange. This combination pack enhances c...